PER 0.00% 10.0¢ percheron therapeutics limited

For General Information, page-491

  1. 3,006 Posts.
    lightbulb Created with Sketch. 504
    Hopefully, the strategic collaboration with US experts on the effects of Long COVID-19 will provide some positive news in the coming months given that inflammation appears to be a contributing factor - this recent article highlights the fact!

    COVID Science: Symptoms linger two years for some; inflammatory protein patterns may provide long COVID clues | Reuters

    "Researchers studied 55 people with long COVID who had been only mildly ill with COVID-19 and found that roughly two-thirds had high levels of inflammatory proteins in their blood, with the ongoing inflammation most likely to be found in individuals with the highest burden of long COVID symptoms. "While earlier research has shown high levels of such proteins in long COVID patients, we provide the first evidence that more than half" have a specific signature, or pattern, while others do not, the researchers reported on Tuesday on bioRxiv ahead of peer review.

    "At least two different patterns of inflammatory proteins were detected," said study leader Troy Torgerson of the Allen Institute for Immunology in Seattle. The existence of these patterns suggests the immune system is being activated in specific ways that could be responsive to treatment with existing anti-inflammatory or immunosuppressive medicines, Torgerson said. "Measurement of these proteins in blood could help to identify long COVID patients who may be good candidates for treatment studies using these drugs or possible future treatments."

    Excerpt from the Quarterly Report April 28th -

    "The Company is looking to capitalise on its deep understanding and experience in inflammatory and immune disease and the power of Somalogic’s large scale proteomics platform testing to help shed light on Long Neuro COVID- 19. This is the first study of its kind in the world in characterizing 7,000 blood plasma changes in Long Neuro COVID-19 patients. The first results from the testing of Long Neuro COVID-19 patient samples are anticipated in mid-2022."

    Definitely need some good news soon to stop the rot!

    GLTAH - hang in there folks for those elusive $$$$ that are still beckoning, maybe this coming XMAS!
    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.